Product Launch (Blog)

Nov, 26 2021

Vietnam Interventional Cardiology Market is Expected to grow at 6.8% CAGR in the Forecast Period of 2021 to 2028

Vietnam Interventional Cardiology Market is growing with factors such as the increased prevalence of cardiovascular disorders and the number of interventional cardiology procedures. However, the complications associated with interventional cardiology and the high cost of interventional cardiology products may obstruct the market's growth in the forecast period.

Vietnam Interventional Cardiology Market Scenario                  

According to Data Bridge Market Research, the market for interventional cardiology in the Vietnam region has the highest market share. The market leader is Boston Scientific Corporation which accounts for an estimated market share of approximately 21.79%. The company has gained outstanding sales through providing interventional cardiology devices in Vietnam.

For instance,

  • In September 2020, Boston Scientific Corporation had declared the investment agreement with an exclusive option to acquire Farapulse, Inc., a privately-held company developing a pulsed-field ablation (PFA) system and catheterization for the treatment of atrial fibrillation (A.F.) and other cardiac arrhythmias. This PFA system – comprising a sheath, generator, and catheters – is intended to ablate heart tissue by creating a therapeutic electric field instead of using thermal energy sources such as radiofrequency ablation or cryoablation. The investment would further progress the U.S. regulatory approval. It would show positive growth in the market

Vietnam Interventional Cardiology MarketTrends Impacting the Market

Now the question is which other regions Boston Scientific Corporation, Terumo Vietnam Medical Equipment Co., Ltd (A Subsidiary Of Terumo Corporation), and Abbott are targeting? Data Bridge Market Research has estimated a large growth in the Vietnam interventional cardiology market and the market leaders targeting Vietnam to be their next revenue pockets for 2021.

The Vietnam interventional cardiology market is becoming more competitive with companies such as Boston Scientific Corporation, Terumo Vietnam Medical Equipment Co., Ltd (A Subsidiary Of Terumo Corporation), and Abbott. They are the top dominating companies in the Vietnam interventional cardiology market, having a maximum number of products. Data Bridge Market Research's new reports highlight the Vietnam interventional cardiology market's major growth factors and opportunities.     

For more analysis on the Vietnam interventional cardiology market, request a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=vietnam-interventional-cardiology-market

Vietnam Interventional Cardiology Market Developments

  • In May 2019, Terumo Corporation announced it had launched the ACG Perfusion and ACG RemoteView System in North America. This helped the company to strengthen its geographical presence further
  • In April 2021, Abbott announced that it had received CE Mark for the TriClip Trans catheter tricuspid valve repair system in the Asia-Pacific region to treat tricuspid regurgitation. This helped the company in diversifying its business

Scope of the Vietnam Interventional Cardiology Market

The Vietnam interventional cardiology market is segmented into six notable segments based on product, type, indication, age, end user, and distribution channel. The Vietnam interventional cardiology market is analyzed based on further segmentation.

  • On the  basis of product, the Vietnam interventional cardiology market is segmented into guidewire, catheters, coronary stents, angioplasty balloon, vascular closure device(VCD), intravascular ultrasound (IVUS), hemodynamic flow alteration devices, plague modification devices, fractional flow reserve (FFR), optical coherence tomography, and accessories. On the basis of type, the Vietnam interventional cardiology market is segmented into conventional and advanced. On the basis of indication, the Vietnam interventional cardiology market is segmented into cardiac catheterization, percutaneous coronary intervention (PCI), coronary thrombectomy, atherectomy, balloon angioplasty, stent implantation, hypothermia/intra-aortic balloon pump, patent foramen ovale closure, and others. On the basis of age, the Vietnam interventional cardiology market is segmented into adult, geriatric, and pediatric. On the basis of end user, the Vietnam interventional cardiology market is segmented into hospitals, cath laboratories, academic and research institutions, and others. On the basis of distribution channel, the Vietnam interventional cardiology market is segmented into direct tender, third party distributor, and retail sales.

To know more about the study https://www.databridgemarketresearch.com/reports/vietnam-interventional-cardiology-market

Key Pointers Covered in the Vietnam Interventional Cardiology Market Industry Trends and Forecast to 2028

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Recent Market Value for Different Countries

Key Market Competitors Covered in the Report

  • Medtronic
  • Teleflex Incorporated
  • Terumo Vietnam Medical Equipment Co., Ltd (A Subsidiary of Terumo Corporation)
  • Abbott
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • USM HEALTHCARE
  • BIOTRONIK
  • Stryker
  • Philips Electronics N.V. (A subsidiary of Koninjlkjke Philps NV)
  • BD
  • Medinol Ltd.
  • AngioDynamics

Above are the key players covered in the report. To know about more an exhaustive list of interventional cardiology companies', contact us  https://www.databridgemarketresearch.com/toc/?dbmr=vietnam-interventional-cardiology-market

Research Methodology: Vietnam Interventional Cardiology Market

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or can drop down your inquiry.

The key research methodology used by the DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market timeline analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis, and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Physicians, Cardiologists, Clinicians and Technicians, Academic Professionals and Researchers
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers, among others.

Related Reports

Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/


Client Testimonials